Home/Filings/4/0001628280-25-052019
4//SEC Filing

Juvenal Tobin W 4

Accession 0001628280-25-052019

CIK 0001447362other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:08 PM ET

Size

8.1 KB

Accession

0001628280-25-052019

Insider Transaction Report

Form 4
Period: 2025-11-11
Juvenal Tobin W
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2025-11-11$35.39/sh500$17,69584,027 total
  • Sale

    Common Stock

    2025-11-12$35.40/sh200$7,08083,827 total
Holdings
  • Common Stock

    (indirect: By Trust)
    2,230
Footnotes (4)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 11, 2024.
  • [F2]This transaction was executed in multiple trades at prices ranging from $35.38 to $35.40, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed at a price of $35.40. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Held by Tobin W and Susan M Juvenal Family Revocable Trust of which the Reporting Person and his spouse are the trustees and the Reporting Person, his spouse and their children are the beneficiaries.

Issuer

CASTLE BIOSCIENCES INC

CIK 0001447362

Entity typeother

Related Parties

1
  • filerCIK 0001856542

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:08 PM ET
Size
8.1 KB